Status:
UNKNOWN
Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
Lead Sponsor:
University of British Columbia
Conditions:
Cellulitis
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE3
Brief Summary
Patients often come to the emergency department with bacterial skin infections (known as "cellulitis"). Some patients with very severe infections are admitted to hospital for antibiotic treatment and ...
Detailed Description
Extended description of the protocol, including information not already contained in other fields. Objective: To compare 400 mg of oral moxifloxacin (Oral Group) once daily to 2 grams of IV cefazolin...
Eligibility Criteria
Inclusion
- Cellulitis requiring outpatient intravenous antibiotic therapy;
- ability to understand,/sign informed consent;
- no contraindications to study medications,
- not pregnant/breastfeeding
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT00323219
Start Date
January 1 2004
End Date
December 1 2013
Last Update
February 8 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Paul's Hospital, Providence Healthcare, Emergency Medicine
Vancouver, British Columbia, Canada, V1Y 1Z1